Abstract
The accompanying therapy prescribed during the use of toxic drugs helps patients to complete the treatment to the end, and the doctor adheres to the treatment of the chosen line The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on chemotherapy tolerance. Materials and methods. The study was conducted in the stem cell treatment department at Republican Specialized Scientific Practical Medical Center of Hematology . Chemotherapy toxicity was assessed according to WHO and NCIC standards. Results. In a comparative study, 30 patients receiving chemotherapy for myeloma with varying degrees of toxicity when fortecarnite (100 mg / kg / day) was added to standard therapy for 2 months or more showed a significant positive change in cytochemical parameters (Alanin transferase (ALT), aspartat transferase (AST)), which allowed the authors recommend metabolic correction to all patients receiving chemotherapy, especially with 2nd and 3rd degree of toxicity.
Highlights
The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on chemotherapy tolerance
The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on the tolerance of chemotherapy
In a comparative analysis of the toxicity of chemotherapy, nausea and vomiting were most often observed, more in the group of patients treated without levocarnitine
Summary
The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on chemotherapy tolerance. The aim of the study was to study the effect of levocarnitine on blood biochemical parameters and on the tolerance of chemotherapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.